EMCDDA Home
  • EN

Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iv) All clients by country and rates of injection of primary drug (%)

CountryYearOpioids % injectingCocaine % injecting Amphetamines % injecting Total % injecting
Belgium(1)200520.610.418.612.6
Bulgaria200882.40.00.079.5
Czech Republic200886.15.080.169.3
Denmark(2)200820.27.83.99.1
Germany(3)200841.023.22.216.6
Estonia200891.463.689.4
Ireland200837.32.20.024.1
Greece200839.25.50.033.7
Spain(4)200718.82.20.58.1
France200823.713.09.410.3
Italy200860.94.40.035.4
Cyprus200865.12.40.036.3
Latvia(5)200892.664.566.9
Lithuania(6)200899.325.061.493.2
Luxembourg200864.645.50.059.0
Hungary200873.96.224.111.5
Malta(7)200675.730.960.9
Netherlands20085.10.42.01.3
Austria200848.711.10.034.1
Poland(8)2007
Portugal(9)2008
Romania200894.90.00.070.6
Slovenia200854.744.452.7
Slovakia200886.30.036.348.9
Finland200882.40.082.062.7
Sweden200852.35.657.030.9
United Kingdom200836.23.624.423.8
Croatia200874.40.70.058.7
Turkey200845.92.80.024.0
Norway
Total42.77.429.023.0

Notes:

 Drug specific percentages are of clients whose primary drug and usual route of administration is known. Total considers all the injection cases regardless of the primary drug being known or not. 

 Injecting as a route of administration is not reported for ecstasy, cannabis and other drugs. 

 When proportion of clients by main drug is 0, ‘% of injectors’ is blank. If no data is available, the symbol ":" is used. 

 (1) Last data available refer to 2005. Data refer only to outpatient and low-threshold agencies. Data do not cover Brussels Capital Region. 

 (2) Most of injection cases have been reported under unknown primary drug. 

 (3) Data on amphetamines refer to stimulants in general. Data on route of administration refer to primary and non primary drugs. 

 (4) Last data available refer to 2007. 

 (5) Data refer only to inpatient centres for which information on all clients have been reported. 

 (6) Data on amphetamines include amphetamines and ecstasy. 

 (7) Last data available refer to 2006. 

 (8) No data available. 

 (9) Data only available for new clients. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — TDI tables V. 1.0-2008 (question 16.1.1) See Table TDI-0 for details on sources. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010